Rongliang Wang Selected Research

Xinnao Shutong

1/2018

Xinnao Shutong Modulates the Neuronal Plasticity Through Regulation of Microglia/Macrophage Polarization Following Chronic Cerebral Hypoperfusion in Rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rongliang Wang Research Topics

Disease

17	Ischemic Stroke 05/2022 - 06/2013
14	Brain Ischemia (Cerebral Ischemia) 01/2021 - 08/2014
12	Stroke (Strokes) 05/2022 - 01/2017
11	Infarction (Infarctions) 12/2019 - 08/2014
10	Ischemia 05/2022 - 08/2014
10	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2020 - 06/2013
7	Reperfusion Injury 04/2018 - 05/2013
5	Cerebral Infarction 01/2019 - 06/2013
3	Brain Edema (Cerebral Edema) 01/2017 - 01/2015
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022 - 01/2018
2	Inflammation (Inflammations) 07/2021 - 01/2020
2	Osteoporosis 01/2020 - 01/2019
2	Bone Fractures (Bone Fracture) 07/2019 - 01/2019
2	Brain Injuries (Brain Injury) 12/2016 - 08/2014
1	Hemorrhagic Stroke 05/2022
1	Hemorrhage 05/2022
1	Cognitive Dysfunction 01/2022
1	Hypersensitivity (Allergy) 07/2021
1	Osteoarthritis 07/2021
1	Pain (Aches) 07/2021
1	COVID-19 02/2021
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021
1	Moyamoya Disease (Moya-Moya Disease) 01/2021
1	Neoplasms (Cancer) 01/2021
1	Glioma (Gliomas) 01/2021
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2020
1	Thrombosis (Thrombus) 01/2020
1	Gliosis 12/2019
1	Atrophy 12/2019
1	Sleep Deprivation 07/2019
1	Hypothermia 06/2018

Drug/Important Bio-Agent (IBA)

6	Neuroprotective AgentsIBA 01/2021 - 08/2015
5	MicroRNAs (MicroRNA)IBA 01/2021 - 06/2013
5	Erythropoietin FDA Link 01/2021 - 01/2015
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2017
3	Interleukin-10 (Interleukin 10)IBA 05/2022 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2013
3	Oxygen (Dioxygen)IBA 01/2020 - 01/2017
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2017
3	AntagomirsIBA 12/2019 - 08/2015
3	triphenyltetrazoliumIBA 01/2019 - 06/2013
3	Small Interfering RNA (siRNA)IBA 01/2017 - 08/2014
2	Interleukin-2 (IL2)IBA 05/2022 - 08/2020
2	CytokinesIBA 05/2022 - 01/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2021 - 01/2017
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2021 - 12/2009
2	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 01/2015
2	TrehaloseIBA 01/2020 - 07/2019
2	Glial Fibrillary Acidic ProteinIBA 12/2019 - 01/2018
2	Therapeutic UsesIBA 07/2019 - 01/2019
2	Messenger RNA (mRNA)IBA 06/2018 - 06/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2015 - 08/2014
2	AntioxidantsIBA 02/2015 - 08/2014
2	Malondialdehyde (Propanedial)IBA 02/2015 - 08/2014
2	Protein Kinases (Protein Kinase)IBA 10/2014 - 08/2014
2	Superoxide DismutaseIBA 10/2014 - 08/2014
1	CD40 Ligand (CD40L)IBA 05/2022
1	Interleukin-5 (Interleukin 5)IBA 05/2022
1	Interleukin-16 (Interleukin 16)IBA 05/2022
1	Lymphotoxin-alpha (Lymphotoxin)IBA 05/2022
1	Interleukin-6 (Interleukin 6)IBA 05/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	BerberineIBA 01/2022
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 07/2021
1	andrographolideIBA 07/2021
1	Type II Tumor Necrosis Factor ReceptorsIBA 07/2021
1	Pharmaceutical PreparationsIBA 02/2021
1	InterleukinsIBA 01/2021
1	UbiquitinIBA 01/2021
1	Class E Scavenger Receptors (Lectin Like Oxidized Low Density Lipoprotein Receptor 1)IBA 01/2021
1	Glutamic Acid (Glutamate)FDA Link 01/2021
1	ChemokinesIBA 01/2021
1	Transfer RNA (tRNA)IBA 01/2021
1	CXC ChemokinesIBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	GTP-Binding Proteins (G-Protein)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Heparin (Liquaemin)FDA LinkGeneric 01/2020
1	AnticoagulantsIBA 01/2020
1	PlatinumIBA 01/2020
1	ReninIBA 01/2020
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2020
1	OsteoprotegerinIBA 01/2020
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2020
1	Ataxin-3IBA 12/2019
1	Histones (Histone)IBA 12/2019
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 12/2019
1	histone deacetylase 3IBA 12/2019
1	DNA (Deoxyribonucleic Acid)IBA 12/2019
1	Eosine Yellowish-(YS) (Eosin)IBA 07/2019
1	Indicators and Reagents (Reagents)IBA 04/2019
1	N- (4- (2- amino- 3- chloropyridin- 4- yloxy)- 3- fluorophenyl)- 4- ethoxy- 1- (4- fluorophenyl)- 2- oxo- 1,2- dihydropyridine- 3- carboxamideIBA 01/2019
1	xuesetongIBA 01/2019
1	SaponinsIBA 01/2019
1	IceIBA 06/2018

Therapy/Procedure

3	Ischemic Postconditioning 01/2018 - 05/2013
2	Aftercare (After-Treatment) 07/2021 - 12/2012
2	Therapeutics 01/2020 - 01/2017
2	Intra-Arterial Infusions 01/2016 - 03/2015
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022